An Open-label, Single-sequence Study to Assess the Effect of Multiple Doses of Tradipitant on Cytochrome P450 3A4 Using Midazolam as a Substrate in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Apr 2016
At a glance
- Drugs Tradipitant (Primary) ; Midazolam
- Indications Pruritus
- Focus Pharmacokinetics
- Sponsors Vanda Pharmaceuticals
- 26 Apr 2016 Status changed from recruiting to completed.
- 08 Dec 2015 New trial record